Innovation & Entrepreneurship

Abstract

On peut toutefois regretter que la robotique et le quantique ne figurent pas davantage parmi les priorités : la France y dispose d'atouts reconnus et gagnerait à porter une ambition plus forte pour faire émerger les futurs champions européens de ces technologies clés, analyse Franck Sebag, associé EY Derrière le rebond français, le plafond de verre européen demeure Alors que l'activité progresse en France, le chiffre d'affaires réalisé par les entreprises françaises en Europe hors France, recule de 2 %. L'enjeu dépasse donc la seule capacité à faire émerger de nouvelles start-up : il porte désormais sur la capacité de la France et de l'Europe à financer leurs technologies, les acheter et leur permettre de changer d'échelle. La présidentielle de 2027 doit donc aussi répondre à une question : voulons-nous rester seulement un pays qui innove, ou devenir un pays capable de transformer cette innovation en puissance économique et technologique ?" Financement, commande publique, accompagnement : les priorités du prochain quinquennat Au-delà de la souveraineté, les réponses des différents acteurs dessinent plusieurs priorités communes pour le futur exécutif. Pour France Digitale, les neuf mois qui viennent devront donc permettre de remettre au cœur du débat public plusieurs choix structurants : orientation de l'épargne vers l'innovation, accès aux marchés de capitaux, commande publique, stabilité des dispositifs fiscaux et réglementaires, simplification administrative et création d'un environnement permettant aux entreprises françaises de grandir à l'échelle européenne."

Abstract

Quality of education, regulatory frameworks governing the biotechnology sector, economic factors, global competition and the potential of AI to democratise spaces were some of the many topics discussed in a wide-ranging conversation at the Biotech Conclave 2026, presented by VIT Chennai in association with The Hindu, on Friday (September 11, 2026). Former principal scientific advisor to the Union government K. VijayRaghavan, who has worked with the National Centre for Biological Sciences and the Tata Institute of Fundamental Research, in conversation with Jacob Koshy, Science Editor, The Hindu, highlighted the importance of fundamental research — despite potential arguments that it was openly available from all over world — still being essential to invest in as today's technologies could not simply be imported without understanding, and that the development of science and curiosity in our context was crucial. Need for contextual regulation On the regulatory frameworks in India, he noted that a lot of regulatory principles, till recently, were drawn from the West and there was an assumption that the more regulations there were, the better it was. The Hindu–VIT Conclave explores advances in biotechnology and healthcare Experts call for stronger industry-academia partnerships to make India a global biopharma hub Biotech students must step out of comfort zones, embrace multiple roles: Suchitra Ella On the new innovations and startup space in biotechnology, Prof. VijayRaghavan said that the sector was growing at a compound annual growth rate (CAGR) of 12-13% or more, with over 1,100 startups started in the last year.

Abstract

Europe could be on the verge of a major overhaul in how promising technologies move from the laboratory to the marketplace. Ekaterina Zaharieva, Commissioner for Startups, Research and Innovation, explained the potential impacts of the landmark initiative: With the European Innovation Act, we are tackling fragmentation head-on: one framework for IP valuation, one digital marketplace connecting buyers and sellers, and one simpler route for public procurement of cutting-edge research and development. That is the Europe we are building." How the European Innovation Act will tackle the funding gap A central problem for innovative companies is that investors and lenders find some of their most valuable assets hard to assess. The European Innovation Act forms part of the EU's broader competitiveness agenda and is now set to move into the legislative process."